Importantly, we found drastic differences when comparing our results with previously published METTL3 target proteins in other cancer cell lines, illustrating the high target specificity of m6A-modified proteins [52] and rationality of the observed inconsistencies. This evidence concerns the gene METTL3 and cancer.